Protein Metrics Enables Biopharmaceutical Industry’s First High Throughput Monoclonal Antibody Sequencing Capability

SAN CARLOS, Calif., June 6, 2016 /PRNewswire-iReach/ -- Protein Metrics today introduced Supernovo, the industry's first software to automate what has been a lengthy manual process of de novo sequencing of monoclonal antibodies (mAbs) by mass spectrometry.  Supernovo enables discovery scientists to quickly sequence hundreds or thousands of monoclonal antibodies against a biological target.

Photo - http://photos.prnewswire.com/prnh/20160602/375074

"Up until now, it might have taken a senior mass spectrometry scientist anywhere from 10 to 25 days to manually inspect, assemble and fully sequence a mAb," says Eric Carlson, Ph.D., VP and Chief Business Officer.  "This has been a huge obstacle to a valuable approach in therapeutic antibody development.  With Supernovo scientists can now apply a high throughput approach to analyzing proteins that show activity against a target.  This capability dramatically shrinks the time taken for the mass spectrometrist to respond to their biologist from a month, to a couple of days".

Supernovo software runs 'hands free,' which means that it automatically assembles individual peptide sequences into the full protein sequence.  Results are displayed in a unique inspection framework so that scientists can review them efficiently prior to reporting out a validated sequence.

The software also allows scientists who no longer have the hybridoma to recover full sequences for proteins.  

"Our collaborators have already demonstrated that if the cDNA or the original cell line is not available, de novo protein sequencing provides a pathway to recombinantly express these mAbs" says Marshall Bern, VP and Director of Research. [See Bogdanoff et al, ACS, DOI: 10.1021/acsinfecdis.6b00026].

"This new capability removes an enormous roadblock from advancing mAb panels into clinically useful mAbs. For any laboratory looking to make leaps in discovery research, SuperNovo will be a game changer", says Dr. Carlson.

About Protein Metrics Inc.

Protein Metrics Inc. is a privately held company serving biopharmaceutical development professionals. The company focuses on the analysis of mass spectrometric and other analytical data on proteins, peptides and glycans. Protein Metrics leverages its experience in mass spectrometry, computer science, and bioinformatics to make analytical results more complete, sensitive, accurate, and easier to achieve.  The company creates software to analyze mass spec and other analytical data to keep pace with the rapid advances in instrumentation. Protein Metrics Inc. is headquartered in San Carlos, California.  For more information, visit www.proteinmetrics.com.

Media Contact:Eric Carlson, Protein Metrics, Inc., 408-600-5540, carlson@proteinmetrics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Protein Metrics Inc.

MORE ON THIS TOPIC